AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29741576 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster-randomized trial methodology with a test-negative design (CR-TND)
Number of subjects: 0
Study 29741576 — intervention group
Group type: COMPARATOR
Intervention: Traditional approaches to cluster-randomized trials
Number of subjects: 0
Study 27485432 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Treatment (CT) using bulk fill composite resin (Scotchbond™ Universal Adhesive system associated with Filtek Bulk Fill - 3 M/ESPE)
Number of subjects: 1214
Study 27485432 — intervention group
Group type: COMPARATOR
Intervention: Atraumatic Restorative Treatment (ART) using high viscosity glass ionomer cement (Ketac Molar Easy Mix - 3 M/ESPE)
Number of subjects: 1214
Study 27485432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis between CT and ART
Number of subjects: 1214
Study 27485432 — intervention group
Group type: EXPERIMENTAL
Intervention: Operator preferences regarding the techniques
Number of subjects: 1214
Study 24262503 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (target cyclosporine level 600-700 ng/ml for first 6 months, 450-550 ng/ml for next 18 months)
Number of subjects: 93
Study 24262503 — intervention group
Group type: COMPARATOR
Intervention: Group B (target cyclosporine level 450-550 ng/ml for first 6 months, 300-400 ng/ml for next 18 months)
Number of subjects: 93
Study 22993341 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azasetron
Number of subjects: 105
Study 22993341 — intervention group
Group type: COMPARATOR
Intervention: Intravenous granisetron
Number of subjects: 105
Study 20827268 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 113
Study 20827268 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 113
Study 18806056 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (1 mg/mL)
Number of subjects: 50
Study 18806056 — intervention group
Group type: COMPARATOR
Intervention: Hydromorphone (0.2 mg/mL)
Number of subjects: 50
Study 16037760 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d
Number of subjects: 5133
Study 16037760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5133
Study 16037760 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 5133
Study 12075577 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG-OB (60 mg weekly for 8 weeks)
Number of subjects: 28
Study 12075577 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 28
Study 9864107 — intervention group
Group type: COMPARATOR
Intervention: Monopolar electrocautery
Number of subjects: 200
Study 9864107 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonically activated shears
Number of subjects: 200
Study 7615761 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-16-infected individuals
Number of subjects: 155
Study 7615761 — intervention group
Group type: COMPARATOR
Intervention: General adult population (control)
Number of subjects: 155
Study 2537721 — intervention group
Group type: EXPERIMENTAL
Intervention: NaHCO3 (300 mg.kg‐1 body mass)
Number of subjects: 7
Study 2537721 — intervention group
Group type: COMPARATOR
Intervention: CaCO3 (placebo, 300 mg.kg‐1 body mass)
Number of subjects: 7
Study 839852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalothin
Number of subjects: 261
Study 839852 — intervention group
Group type: COMPARATOR
Intervention: Methicillin
Number of subjects: 261
Study 6455388 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical clindamycin phosphate
Number of subjects: 0
Study 6455388 — intervention group
Group type: COMPARATOR
Intervention: Topical tetracycline hydrochloride
Number of subjects: 0
Study 31477088 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led physical activity intervention (PLAN-A)
Number of subjects: 52
Study 29324264 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-week education program about sleep and driving
Number of subjects: 34
Study 29324264 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 34
Study 26264173 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise during hemodialysis sessions with ankle weights and resistance bands, performed twice a week for 12 weeks
Number of subjects: 61
Study 26264173 — intervention group
Group type: COMPARATOR
Intervention: Control group (hemodialysis session alone)
Number of subjects: 61
Study 24479839 — intervention group
Group type: EXPERIMENTAL
Intervention: Early initiation of exercise programme on post-operative day 1
Number of subjects: 77
Study 24479839 — intervention group
Group type: COMPARATOR
Intervention: Late initiation of exercise programme after removal of the drain
Number of subjects: 77
Study 22414200 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-36 (36-item Medical Outcomes Study Short Form Survey)
Number of subjects: 9423
Study 20854696 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block injection
Number of subjects: 66
Study 20854696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 17986319 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical repair followed by functional rehabilitation using tape bandage
Number of subjects: 72
Study 17986319 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment followed by functional rehabilitation with use of a functional bracing system
Number of subjects: 72
Study 17986319 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical repair
Number of subjects: 72
Study 17986319 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 72
Study 15847890 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid (VIA)
Number of subjects: 5010
Study 15847890 — intervention group
Group type: COMPARATOR
Intervention: Cytological smears (Pap smear)
Number of subjects: 5010
Study 12032722 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose cyclosporine A (15 mg/kg/day for 2 days, 7.5 mg/kg/day for 2 days, then adjusted to maintain trough blood levels of 100-200 microg/l)
Number of subjects: 34
Study 12032722 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose cyclosporine A (2 mg/kg/day with no loading dose)
Number of subjects: 34
Study 9661611 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterozygous relatives (n=58)
Number of subjects: 165
Study 9661611 — intervention group
Group type: COMPARATOR
Intervention: Homozygous normal relatives (n=37)
Number of subjects: 165
Study 9661611 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterozygous relatives (n=33)
Number of subjects: 165
Study 9661611 — intervention group
Group type: COMPARATOR
Intervention: Homozygous normal relatives (n=29)
Number of subjects: 165
Study 9661611 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental height SDS of affected offspring
Number of subjects: 165
Study 9661611 — intervention group
Group type: EXPERIMENTAL
Intervention: Unaffected siblings (normals or carriers)
Number of subjects: 165
Study 7650300 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric orthopaedic nursing education program
Number of subjects: 26
Study 2696890 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime i.v. (2 g) in three doses (half an hour before surgery, 8 and 16 hours from the first dose)
Number of subjects: 22
Study 2696890 — intervention group
Group type: COMPARATOR
Intervention: Netilmicin (100 mg) plus clindamycin (600 mg i.v.), following the same chronological schedule
Number of subjects: 22
Study 330290 — intervention group
Group type: EXPERIMENTAL
Intervention: Lentizol 50 mg
Number of subjects: 50
Study 330290 — intervention group
Group type: COMPARATOR
Intervention: Tryptizol 75 mg
Number of subjects: 50
Study 31030773 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 182
Study 31030773 — intervention group
Group type: COMPARATOR
Intervention: Conventional phacoemulsification
Number of subjects: 182
Study 29283612 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure for Primary Care (PE-PC)
Number of subjects: 67
Study 29283612 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment minimal contact control
Number of subjects: 67
Study 25641533 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 3602
Study 25641533 — intervention group
Group type: COMPARATOR
Intervention: Heparin and glycoprotein IIb/IIIa inhibitor
Number of subjects: 3602
Study 25641533 — intervention group
Group type: EXPERIMENTAL
Intervention: Bare-metal stents
Number of subjects: 3602
Study 25641533 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents
Number of subjects: 3602
Study 25641533 — intervention group
Group type: EXPERIMENTAL
Intervention: Target vessel revascularization (TVR)
Number of subjects: 3602
Study 24060269 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute low-intensity cycling for one hour at 50% of maximum oxygen uptake
Number of subjects: 30
Study 24060269 — intervention group
Group type: COMPARATOR
Intervention: Control condition (three hours of rest)
Number of subjects: 30
Study 24060269 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute low-intensity cycling
Number of subjects: 30
Study 24060269 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute low-intensity exercise
Number of subjects: 30
Study 21345470 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercises + progressive relaxation techniques
Number of subjects: 56
Study 21345470 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham treatment with disconnected magnet therapy device)
Number of subjects: 56
Study 20031818 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative coronary artery revascularization
Number of subjects: 462
Study 20031818 — intervention group
Group type: COMPARATOR
Intervention: No preoperative revascularization
Number of subjects: 462
Study 16860808 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20mg/day
Number of subjects: 35
Study 16860808 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 40mg/day
Number of subjects: 35
Study 15118489 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion sustained release
Number of subjects: 0
Study 15118489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10831175 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release lanreotide (SR-L) 30 mg
Number of subjects: 7
Study 10831175 — intervention group
Group type: COMPARATOR
Intervention: Control group (7 normal subjects)
Number of subjects: 7
Study 9505983 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1 to 80 mg)
Number of subjects: 24
Study 9505983 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (1.25 to 100 mg)
Number of subjects: 24
Study 9505983 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (multiple doses)
Number of subjects: 24
Study 8415211 — intervention group
Group type: EXPERIMENTAL
Intervention: Human insulin
Number of subjects: 31
Study 8415211 — intervention group
Group type: COMPARATOR
Intervention: MC pork insulin
Number of subjects: 31
Study 2937338 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 8 micrograms kg‐1
Number of subjects: 41
Study 2937338 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 41
Study 31421583 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified PNF + Maximum Copresence
Number of subjects: 235
Study 31421583 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified PNF Only
Number of subjects: 235
Study 31421583 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified PNF + Visual Copresence
Number of subjects: 235
Study 31421583 — intervention group
Group type: COMPARATOR
Intervention: Standard PNF
Number of subjects: 235
Study 28615149 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg twice daily
Number of subjects: 428
Study 28615149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 428
Study 25956604 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor practice (MP) - wrist extension‐flexion visuomotor skill for 20 min
Number of subjects: 11
Study 25956604 — intervention group
Group type: COMPARATOR
Intervention: Attentional control (AC) - watched templates without movements (n = 11, mean age 70.5 years)
Number of subjects: 11
Study 25956604 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticospinal excitability during contraction at 20% of maximal force
Number of subjects: 11
Study 25956604 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracortical inhibition and facilitation metrics
Number of subjects: 11
Study 22796996 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion
Number of subjects: 24
Study 22796996 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast bath therapy
Number of subjects: 24
Study 22796996 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 22796996 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion and contrast bath therapy
Number of subjects: 24
Study 21239049 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod treatment
Number of subjects: 26
Study 17700579 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard diet (omnivorous)
Number of subjects: 176
Study 17700579 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian diet (lacto-ovo-vegetarian)
Number of subjects: 176
Study 17700579 — intervention group
Group type: COMPARATOR
Intervention: Diet of choice (standard)
Number of subjects: 176
Study 17700579 — intervention group
Group type: COMPARATOR
Intervention: Diet of choice (vegetarian)
Number of subjects: 176
Study 16926578 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with nonspecific musculoskeletal disorders
Number of subjects: 78
Study 16926578 — intervention group
Group type: COMPARATOR
Intervention: Matched control group of nonpatients
Number of subjects: 78
Study 12574806 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous unfractionated heparin (UFH)
Number of subjects: 885
Study 12574806 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous low-molecular-weight heparin (reviparin) twice daily for one week
Number of subjects: 885
Study 12574806 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous reviparin once daily for four weeks
Number of subjects: 885
Study 12574806 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants for at least 3 months
Number of subjects: 885
Study 12574806 — intervention group
Group type: COMPARATOR
Intervention: Non-responders
Number of subjects: 885
Study 10501793 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium 1 g twice daily for 12 months
Number of subjects: 30
Study 10501793 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium 1 g twice daily for 12 months plus intranasal calcitonin 400 IU/day for the first month and then 200 IU/day for 11 months
Number of subjects: 30
Study 10501793 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment (Control)
Number of subjects: 30
Study 10501793 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (Calcium with or without calcitonin)
Number of subjects: 30
Study 8832013 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of low-dose heparin (100 units/kg/day) from the first day of the preparative regimen to day +30 or until discharge.
Number of subjects: 50
Study 8832013 — intervention group
Group type: COMPARATOR
Intervention: Control group (historical controls) receiving BMT for a variety of disorders, total of 70 patients.
Number of subjects: 50
Study 1848167 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa (100 mg)
Number of subjects: 6
Study 1848167 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin II infusion (0.5 and 1.0 ng min-1 kg-1)
Number of subjects: 6
Study 6353127 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical conditioning group (8‐wk progressive aerobic exercise program, 30 min/d for 4 d each wk)
Number of subjects: 50
Study 6353127 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 30367457 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug A at the optimal phase I‐II dose
Number of subjects: 0
Study 30367457 — intervention group
Group type: COMPARATOR
Intervention: Control treatment C
Number of subjects: 0
Study 29247172 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (60 mg iron as ferrous fumarate daily)
Number of subjects: 327
Study 29247172 — intervention group
Group type: COMPARATOR
Intervention: Baseline (before supplementation)
Number of subjects: 327
Study 26713821 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional counselling with caloric restriction for 12 months
Number of subjects: 80
Study 26713821 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical care alone
Number of subjects: 80
Study 24864481 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwater shower massage and electrical stimulation
Number of subjects: 120
Study 22591506 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 20
Study 22591506 — intervention group
Group type: COMPARATOR
Intervention: Control (plaster cast immobilization)
Number of subjects: 20
Study 20450458 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic neck pain patients exerting to their 20% maximum voluntary contraction (MVC), pain threshold, and pain tolerance levels.
Number of subjects: 67
Study 20450458 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls exerting to their 20% MVC, 60% MVC, and MVC.
Number of subjects: 67
Study 20450458 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavelet decomposition with principal component analysis at 20% MVC.
Number of subjects: 67
Study 20450458 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavelet decomposition with principal component analysis at pain threshold/60% MVC.
Number of subjects: 67
Study 17322539 — intervention group
Group type: EXPERIMENTAL
Intervention: pemetrexed 500 mg/m(2)
Number of subjects: 571
Study 17322539 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel 75 mg/m(2)
Number of subjects: 571
Study 17322539 — intervention group
Group type: COMPARATOR
Intervention: first-line therapy types (gemcitabine + platinum, taxane + platinum, other therapies)
Number of subjects: 571
Study 15803358 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate treatment
Number of subjects: 252
Study 15803358 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 252
Study 12225716 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg once daily
Number of subjects: 0
Study 12225716 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (Adizem XL) 300 mg once daily
Number of subjects: 0
Study 12225716 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/atenolol
Number of subjects: 0
Study 12225716 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem (Adizem XL)/isosorbide 5‐mononitrate
Number of subjects: 0
Study 12225716 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/atenolol during drug-free interval
Number of subjects: 0
Study 10212715 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 5 micrograms.kg‐1 and propofol 2.5 mg.kg‐1 (Group A5)
Number of subjects: 150
Study 10212715 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 10 micrograms.kg‐1 and propofol 2.5 mg.kg‐1 (Group A10)
Number of subjects: 150
Study 10212715 — intervention group
Group type: COMPARATOR
Intervention: Propofol 2.5 mg.kg‐1 only (Group P)
Number of subjects: 150
Study 7600753 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured teaching and treatment programme
Number of subjects: 108
Study 7600753 — intervention group
Group type: COMPARATOR
Intervention: Control group (no programme)
Number of subjects: 108
Study 7600753 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 108
Study 1516498 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil treatment (n = 59)
Number of subjects: 135
Study 1516498 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 135
Study 1516498 — intervention group
Group type: EXPERIMENTAL
Intervention: NIDDM patients
Number of subjects: 135
Study 1516498 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic participants
Number of subjects: 135
Study 6337667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 6337667 — intervention group
Group type: EXPERIMENTAL
Intervention: Emepronium bromide 200 mg qid
Number of subjects: 19
Study 6337667 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavoxate chloride 200 mg qid
Number of subjects: 19
Study 30782512 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 101
Study 30782512 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 101
Study 29735474 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent technology‐based intervention targeting adherence to daily controller medication (2 sessions of computer‐delivered motivational interviewing and individualized text messaging)
Number of subjects: 192
Study 29735474 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving computer‐delivered asthma education modules and general text messages about asthma
Number of subjects: 192
Study 25577741 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100mg
Number of subjects: 27
Study 25577741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 24289574 — intervention group
Group type: EXPERIMENTAL
Intervention: Basant polyherbal vaginal cream
Number of subjects: 287
Study 24289574 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin vaginal capsules
Number of subjects: 287
Study 24289574 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal cream
Number of subjects: 287
Study 24289574 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal capsules
Number of subjects: 287
Study 21986570 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of calcium L-threonate (675, 2025, or 4050 mg)
Number of subjects: 24
Study 21986570 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated doses of calcium L-threonate (2025 mg twice daily for 4 days)
Number of subjects: 24
Study 21986570 — intervention group
Group type: COMPARATOR
Intervention: Fasted subjects
Number of subjects: 24
Study 21986570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative urinary excretion of L-threonate
Number of subjects: 24